Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and efficacy of Universal Infuenza Vaccine in healthy volunteers

Trial Profile

Safety and efficacy of Universal Infuenza Vaccine in healthy volunteers

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 08 Jun 2020 According to an Intravacc media release, Intravacc and Versatope have signed a research service agreement under which Intravacc will provide its services to Versatope in bringing VT-105 towards first clinical trials.
  • 10 Oct 2019 New trial record
  • 25 Sep 2019 According to a Versatope Therapeutics media release, NIAID funding will support human clinical studies to demonstrate safety and tolerability in healthy volunteers.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top